相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
1
100.0%
暂无批准数据
- Iterative Health raised $77 million in Series C funding led by Google Ventures and Intrepid Growth Partners to scale its AI-powered clinical research network platform. - The company plans to expand its platform applications from gastroenterology and hepatology into cardiology and obesity therapeutic areas while growing its geographic reach. - Iterative's network currently includes over 100 research sites across four continents and partnerships with more than 40 biotech, pharma, medical device companies and CROs. - The platform aims to address clinical trial recruitment challenges by providing centralized access to diverse patient populations and faster site activation rates.
- Iterative Health partnered with US Heart & Vascular to advance community-based cardiovascular research, adding USHV research sites to its global network spanning over 100 sites across three continents. - The company acquired three cardiology sites from NextStage Clinical Research in Texas, expanding its cardiovascular research capabilities in key markets where cardiovascular disease affects nearly half of all U.S. adults. - These strategic moves reinforce Iterative Health's position as a trusted research partner across therapeutic areas, now spanning GI, hepatology, obesity, and cardiovascular care with industry-leading trial performance. - The expansion aims to improve patient access to innovative cardiovascular therapies and devices in community care settings where trusted physician-patient relationships already exist.
